A fine taste of growth

13/10/26 -"Givaudan delivered a strong quarter, reaffirming its leading position in fragrances. Fine Fragrance continues to resist the normalisation anticipated by management, while Taste & Wellbeing is ..."

Executive summary
Conflict of interest

Pages

Language

English

Published on

13/10/26

Download

You may also be interested by these reports :

13/10/26

Givaudan

Givaudan delivered a strong quarter, reaffirming its leading position in fragrances. Fine Fragrance continues to resist the normalisation anticipated ...

07/10/26

K+S

2026E: The reduction in our EPS estimate mainly reflects a more cautious view on potash prices in H2 2026, compounded by likely higher freight costs. ...

07/10/26

Chemicals

The FT reports that the European Commission’s pesticide omnibus, which partly mirrors industry lobbying, intends to make approvals unlimited, ease ...

02/10/26

KWS SAAT SE & Co. KGaA

Lower earnings expectations but a positive CMD impression

EXECUTIVE SUMMARY

Updates

Pension Risks

Target & Opinion

Governance & Management

Business & Trends

Graphics : Momentum

Money Making

Graphics : MACD & Volumes

Debt

Graphics : Sensitivities

Valuation

Sector: Performance

DCF

Sector: Key data

NAV/SOTP

Sector: Ratios & Valorisation

Worth knowing

Sector: Peers

Financials

Sector: Analysis

CONFLICTS OF INTEREST

AlphaValue does not have nor seek any business with companies covered in AlphaValue Research paid by subscription. As a result, investors can be confident that there is no conflict of interest that could affect the objectivity of AlphaValue Research.

Corporate broking

Trading in corporate shares

Analyst ownership

Advising of corporate (strategy, marketing, debt, etc)

Research paid for by corporate

Provision of corporate access paid for by corporate

Link between and a banking entity

Brokerage activity at AlphaValue